Skip to main content
Smart Investors Daily
VA

OTC · VASO

Vaso Corporation

Healthcare · Medical - Healthcare Information Services

$0.26

Down-$0.00 (-1.14%)

Updated Aug 14, 2026, 3:09 AM

SID Score

5.4/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
29.85M
P/E ratio
11.52
Dividend yield
0.00%
52-week range
— – —
Volume
133.55K
Avg. volume
177.26K

Price performance

VASO price history

1M range · 0 trading sessions · Daily adjusted prices

VASO does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest VASO news

The latest Smart Investors Daily articles mentioning VASO.

VASO research

Overview

Company profile and research snapshot.

Company profile

VASO CORPORATION

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jul 23, 2026

Vaso Corporation Appoints Shaun McMeans to Board of Directors

PLAINVIEW, N.Y., July 23, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and IT services, professional sales services and proprietary medical products, today announced the appointment of Shaun McMeans to the Company’s Board of Directors, effective July 23, 2026. “We are pleased to welcome Shaun to Vaso’s Board of Directors,” said Dr. Jun Ma, President and Chief Executive Officer of Vaso Corporation. “Sh

Yahoo · Nov 19, 2025

Vaso Corporation Announces Divestiture of Subsidiary

Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 Investor Contact:Jonathan NewtonInvestor RelationsPhone: 516-997-4600 Email: [email protected] PLAINVIEW, N.Y, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services and proprietary medical products, announced today that it had reached a

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.